SHFH
Scientist Home Future Health Limited
Price Chart
Latest Quote
$1.07
+0.00 (+0.00%)
Current Price
| Previous Close | $1.07 |
| Open | $1.52 |
| Day High | $1.52 |
| Day Low | $1.07 |
| Volume | 500 |
Stock Information
| Shares Outstanding | 23.72M |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Market Cap | $25.38M |
| EPS (TTM) | $-0.02 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Book/sh | $0.01 |
| Employees | 6 |
Financial Ratios
Returns & Margins
Ownership
| Insider Ownership | 84.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 214.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.64 |
| SMA50 | $4.77 |
| ATR | 0.0450 |
Performance History
| Week | -37.06% |
| Month | -38.86% |
| Quarter | -43.68% |
| YTD | -40.56% |
| 10 Years | -40.56% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-30 | $1.07 | 0 |
| 2026-10-29 | $1.07 | 500 |
| 2026-10-28 | $1.70 | 0 |
| 2026-10-27 | $1.70 | 0 |
| 2026-10-26 | $1.70 | 0 |
| 2026-10-23 | $1.70 | 0 |
| 2026-10-22 | $1.70 | 0 |
| 2026-10-21 | $1.70 | 296 |
| 2026-10-20 | $1.70 | 0 |
| 2026-10-19 | $1.70 | 0 |
| 2026-10-16 | $1.70 | 0 |
| 2026-10-15 | $1.70 | 0 |
| 2026-10-14 | $1.70 | 0 |
| 2026-10-13 | $1.70 | 0 |
| 2026-10-12 | $1.70 | 0 |
| 2026-10-09 | $1.70 | 0 |
| 2026-10-08 | $1.70 | 0 |
| 2026-10-07 | $1.70 | 0 |
| 2026-10-06 | $1.70 | 0 |
| 2026-10-05 | $1.70 | 333 |
| 2026-10-02 | $1.75 | 0 |
| 2026-10-01 | $1.75 | 0 |
| 2026-09-30 | $1.75 | 0 |
About Scientist Home Future Health Limited
Scientist Home Future Health Limited, through its subsidiaries, engages in the retail trading of health supplements and topical creams, and provides physical check-up services in Hong Kong. The company offers Scientist Home Vein Cream, Scientist Home Calcification Cream, Scientist Home Spermaceti Cream, Scientist Home Bone Gelatine Hydrolysate, Scientist Home Mixed Gelatine Hydrolysate, Scientist Home High Concentration Proteinase, and Scientist Home Cholipolysis Cholic Acid products. It also provides health consultations through nutrition specialists and operates health and wellness services for preventive healthcare and wellness support. The company was incorporated in 2024 and is based in Kwun Tong, Hong Kong.
đ° Latest News
No news articles available at the moment. Check back later for updates on SHFH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 |
|---|---|
| Revenue | |
| Reconciled Cost Of Revenue | $122,168 |
| Cost Of Revenue | $122,168 |
| Total Revenue | $204,055 |
| Operating Revenue | $204,055 |
| Expenses | |
| Total Expenses | $435,780 |
| Operating Expense | $313,612 |
| Income & Earnings | |
| Net Income From Continuing Operation Net Minority Interest | $-231,725 |
| Normalized Income | $-231,725 |
| Net Income From Continuing And Discontinued Operation | $-231,725 |
| Total Operating Income As Reported | $-231,725 |
| Net Income Common Stockholders | $-231,725 |
| Net Income | $-231,725 |
| Net Income Including Noncontrolling Interests | $-231,725 |
| Net Income Continuous Operations | $-231,725 |
| Pretax Income | $-231,725 |
| Operating Income | $-231,725 |
| Gross Profit | $81,887 |
| Other | |
| Tax Effect Of Unusual Items | $0 |
| Tax Rate For Calcs | $0 |
| Normalized EBITDA (Bullshit earnings) | $-205,233 |
| Reconciled Depreciation | $26,492 |
| EBITDA (Bullshit earnings) | $-205,233 |
| EBIT | $-231,725 |
| Diluted NI Availto Com Stockholders | $-231,725 |
| Tax Provision | $0 |
| Selling General And Administration | $313,612 |
Fetched: 2026-05-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $113,391 | $-6,020 |
| Total Assets | $644,365 | $21,248 |
| Total Non Current Assets | $452,119 | $0 |
| Current Assets | $192,246 | $21,248 |
| Prepaid Assets | $89,352 | $0 |
| Inventory | $34,006 | $2,627 |
| Cash Cash Equivalents And Short Term Investments | $68,888 | $18,621 |
| Cash And Cash Equivalents | $68,888 | $18,621 |
| Debt | ||
| Total Debt | $390,683 | $0 |
| Long Term Debt And Capital Lease Obligation | $316,516 | $0 |
| Current Debt And Capital Lease Obligation | $74,167 | - |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $530,974 | $27,268 |
| Total Non Current Liabilities Net Minority Interest | $316,516 | $0 |
| Current Liabilities | $214,458 | $27,268 |
| Payables And Accrued Expenses | $140,291 | $27,268 |
| Payables | $116,588 | $12,268 |
| Other Payable | $20,932 | - |
| Total Tax Payable | $1,831 | $1,826 |
| Income Tax Payable | $1,831 | $1,826 |
| Equity | ||
| Common Stock Equity | $113,391 | $-6,020 |
| Total Equity Gross Minority Interest | $113,391 | $-6,020 |
| Stockholders Equity | $113,391 | $-6,020 |
| Gains Losses Not Affecting Retained Earnings | $-2,864 | $0 |
| Other Equity Adjustments | $-2,864 | - |
| Retained Earnings | $-246,705 | $-14,980 |
| Other | ||
| Ordinary Shares Number | $23,716,000 | $23,716,000 |
| Share Issued | $23,716,000 | $23,716,000 |
| Tangible Book Value | $113,391 | $-6,020 |
| Invested Capital | $113,391 | $-6,020 |
| Working Capital | $-22,212 | $-6,020 |
| Capital Lease Obligations | $390,683 | $0 |
| Total Capitalization | $113,391 | $-6,020 |
| Additional Paid In Capital | $360,588 | $6,612 |
| Capital Stock | $2,372 | $2,348 |
| Common Stock | $2,372 | $2,348 |
| Long Term Capital Lease Obligation | $316,516 | $0 |
| Current Capital Lease Obligation | $74,167 | $0 |
| Current Accrued Expenses | $23,703 | $15,000 |
| Dueto Related Parties Current | $93,825 | $10,442 |
| Net PPE | $452,119 | $0 |
| Accumulated Depreciation | $-1,717 | $0 |
| Gross PPE | $453,836 | $0 |
| Machinery Furniture Equipment | $74,892 | $0 |
| Buildings And Improvements | $378,944 | $0 |
| Properties | $0 | $0 |
| Finished Goods | $34,006 | $2,627 |
Fetched: 2026-05-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 |
|---|---|
| Free Cash Flow | |
| Free Cash Flow | $-323,052 |
| Operating Activities | |
| Operating Cash Flow | $-248,278 |
| Cash Flow From Continuing Operating Activities | $-248,278 |
| Investing Activities | |
| Capital Expenditure | $-74,774 |
| Investing Cash Flow | $-74,774 |
| Cash Flow From Continuing Investing Activities | $-74,774 |
| Financing Activities | |
| Issuance Of Capital Stock | $354,000 |
| Financing Cash Flow | $376,140 |
| Cash Flow From Continuing Financing Activities | $376,140 |
| Net Other Financing Charges | $22,140 |
| Net Common Stock Issuance | $354,000 |
| Common Stock Issuance | $354,000 |
| Other | |
| Interest Paid Supplemental Data | $0 |
| Income Tax Paid Supplemental Data | $0 |
| End Cash Position | $68,888 |
| Beginning Cash Position | $18,621 |
| Effect Of Exchange Rate Changes | $-2,821 |
| Changes In Cash | $53,088 |
| Net PPE Purchase And Sale | $-74,774 |
| Purchase Of PPE | $-74,774 |
| Change In Working Capital | $-43,045 |
| Change In Other Current Liabilities | $-13,058 |
| Change In Payables And Accrued Expense | $90,551 |
| Change In Payable | $90,551 |
| Change In Tax Payable | $0 |
| Change In Income Tax Payable | $0 |
| Change In Prepaid Assets | $-89,214 |
| Change In Inventory | $-31,324 |
| Depreciation Amortization Depletion | $26,492 |
| Depreciation And Amortization | $26,492 |
| Depreciation | $26,492 |
| Net Income From Continuing Operations | $-231,725 |
Fetched: 2026-05-21